The estimated Net Worth of Thomas E Griffin is at least $2.68 millier dollars as of 13 April 2018. Thomas Griffin owns over 3,346 units of Helius Medical Technologies Inc stock worth over $2,677 and over the last 8 years Thomas sold HSDT stock worth over $0.
Sign up
Thomas Griffin HSDT stock SEC Form 4 insiders trading
Thomas has made over 1 trades of the Helius Medical Technologies Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Thomas bought 3,346 units of HSDT stock worth $24,995 on 13 April 2018.
The largest trade Thomas's ever made was buying 3,346 units of Helius Medical Technologies Inc stock on 13 April 2018 worth over $24,995. On average, Thomas trades about 669 units every 0 days since 2017. As of 13 April 2018 Thomas still owns at least 3,346 units of Helius Medical Technologies Inc stock.
You can see the complete history of Thomas Griffin stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Thomas Griffin's mailing address?
Thomas's mailing address filed with the SEC is C/O HELIUS MEDICAL TECHNOLOGIES, INC., 642 NEWTOWN YARDLEY ROAD, SUITE 100, NEWTOWN, PA, 18940.
Insiders trading at Helius Medical Technologies Inc
Over the last 9 years, insiders at Helius Medical Technologies Inc have traded over $0 worth of Helius Medical Technologies Inc stock and bought 1,827,117 units worth $3,547,767 . The most active insiders traders include Dane Andreeff, Blane Walter et Philippe Deschamps. On average, Helius Medical Technologies Inc executives and independent directors trade stock every 121 days with the average trade being worth of $58,628. The most recent stock trade was executed by Dane Andreeff on 14 December 2023, trading 5,000 units of HSDT stock currently worth $40,500.
What does Helius Medical Technologies Inc do?
helius medical technologies, inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. the company's product is portable neuromodulation stimulator (pons), a medical device in canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. its pons device treats neurostimulation of cranial nerves via the tongue to restore lost function. the company is headquartered in newtown, pennsylvania.
What does Helius Medical Technologies Inc's logo look like?
Complete history of Thomas Griffin stock trades at Helius Medical Technologies Inc
Helius Medical Technologies Inc executives and stock owners
Helius Medical Technologies Inc executives and other stock owners filed with the SEC include:
-
Jeffrey S. Mathiesen CPA, CPA,
CFO & Treasurer -
Dane Carl Andreeff,
Pres, CEO & Director -
Dr. Brian W. Bapty Ph.D.,
VP of Strategy and Bus. Devel. -
Dr. Antonella Favit-Van Pelt M.D., Ph.D.,
Chief Medical Officer -
Frederick Fantazzia,
VP of Sales & Marketing- North America -
Joyce N La Viscount,
CFO and COO -
Mitch E Tyler,
Director -
Edward M Straw,
-
Jonathan Sackier,
Chief Medical Officer -
Thomas E Griffin,
Director -
Huaizheng Peng,
Director -
Jennifer Laux,
Chief Commercial Officer -
Philippe Deschamps,
President and CEO -
Brian Bapty,
Vice President -
Pelt Antonella R. Favit Van,
Chief Medical Officer -
Paul Buckman,
-
Blane Walter,
-
Jeffrey S Mathiesen,
CFO and Treasurer -
Sherrie L Perkins,